In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim ...
New research offers what scientists describe as the first biological evidence of Long COVID brain fog. View on euronews ...
Researchers in Japan have pinpointed a biological cause of Long COVID brain fog using advanced PET brain imaging. They ...
Key pointsA Florey study in mice has found that offspring conceived after a father has been infected with the SARS-CoV-2 virus and developed COVID-19 ...
MedPage Today on MSN
COVID Vaccines Still Effective Against Severe Outcomes, VA Study Suggests
Looking at COVID-associated outcomes in nearly 300,000 veterans at 6 months, the estimated vaccine effectiveness was 29.3% ...
Use of remdesivir and/or nirmatrelvir/ritonavir in patients hospitalised for acute SARS-CoV-2 is tied to fewer deaths during ...
Children who experience Covid reinfection are twice as likely to develop long-term symptoms, including fatigue, heart ...
XFG, a recombinant of LF.7 and LP.8.1.2, is growing globally and predominates in Europe, although its impact on hospitals remains limited according to the ECDC and WHO.
FORT LAUDERDALE, FL / ACCESS Newswire / October 9, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback